AI assistant
Intrasense Regulatory Filings 2021
1447_iss_2021-09-14_6b8f44fe-49da-476b-b0f4-9fa6d66bb5a7.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Press release
Montpellier, France, September 14, 2021 – 5:45 pm CEST
Intrasense participates in the SIFEM 2021 congress from September 17 to 19
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and Myrian® designer is pleased to announce its participation in the congress of the Société d'Imagerie de la Femme, in Ajaccio from September 17 to 19.
The Society for Imaging of Women and the promotion of diagnostic and therapeutic imaging
The SIFEM, a society whose purpose is to promote diagnostic and therapeutic imaging of the female pelvis and breast, is a major player in the care of women in radiology. Its annual congress, a major event in this field for French-speaking countries, is held alternately in different regions of France or exceptionally in neighbouring countries such as Luxembourg, Belgium, or the Principality of Monaco.
This event highlights the state of the art in imaging as well as organizational aspects (screening in particular) or patient management methods (cancer plan). In total, more than 1,000 attendees are expected during the 3-day event, at the various conferences and the technical exhibition.
Intrasense presents its mammography, tomosynthesis and breast MRI solutions
Breast cancer remains the most common cancer in women and is the subject of screening strategies in most developed countries. In this context, Intrasense offers a breast imaging solution, from screening to therapeutic follow-up, with all the necessary diagnostic tools, thus allowing patients to be managed throughout the entire treatment process, with a single platform.
The latest versions of Myrian XP-Mammo and Myrian XP-Breast (breast MRI) will be presented by the company's teams during the event.
About Intrasense
Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1000 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system. Intrasense has more than 40 employees among which 15 are dedicated to Research & Development. Intrasense has been labelled 'innovative company' by the BPI and has invested more than 10 million euros in Research & Development since its creation. More information on: www.intrasense.fr
Contacts
Intrasense Jérémy Peyron Marketing & Communication manager 1231 avenue du Mondial 98, 34000 Montpellier, FRANCE Tel: +334 67 130 130 [email protected]
NewCap Investor Relations and Financial Communication Louis Tilquin Paris, FRANCE Tel: +331 44 71 20 40 [email protected]